INSP
Inspire Medical Systems, Inc.
NYSE · Healthcare · Medical - Devices · US
$76.78
+5.55%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$72.55
From 52W high−46.68%
Volume2.05M
Market cap$2.22B
P/E (TTM)16.5x
P/S (TTM)2.5x
Div yield—
Key dataSep 18, 2026
Open
$72.55
From 52W high
−46.68%
Volume
2.05M
Market cap
$2.22B
ValuationView details →
P/E (Fwd)
60.3x
EV/EBITDA
23.2x
P/E (TTM)
16.5x
RSI (14)
78.0
MomentumView details →
1D Return
+5.55%
YTD Return
−14.83%
SummaryUpdated Jun 1, 2026
Inspire Medical Systems, Inc. (NYSE:INSP) is a medical technology company founded in 2007 and headquartered in Golden Valley, Minnesota. The company went public in May 2018 and has established itself as a pioneer in neurostimulation therapy for obstructive sleep apnea (OSA). Since its founding, Inspire has grown from a development-stage company to a profitable enterprise that has treated over 100,000 patients worldwide. The company achieved its first full year of profitability in 2024, marking a significant milestone in its commercial journey.
Similar companies
Latest newsMore news →
Bank of America Corp DE reduced its stake in Inspire Medical Systems, Inc. by 11.4% during the quarter, selling 24,057 shares, according to its 13F filing.26d agoInspire Medical Systems reported second quarter 2026 financial results with revenue of $200.6 million, diluted EPS of $0.01, adjusted diluted EPS of $0.14, and operating cash flow of $23.2 million, and raised its 2026 guidance and announced a strategic growth plan to redeploy $30 million for growth initiatives.48d ago